Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

June 7, 2021

Study Completion Date

December 20, 2022

Conditions
Non-small Cell Lung CancerUrothelial Cancer
Interventions
DRUG

Avelumab 800 mg in combination with pemetrexed / carboplatin

Avelumab Pemetrexed Carboplatin

DRUG

Avelumab 800 mg in combination with gemcitabine / cisplatin.

Avelumab Gemcitabine Cisplatin

DRUG

Avelumab 1200 mg in combination with pemetrexed/carboplatin

Avelumab Pemetrexed Carboplatin

DRUG

Avelumab 1200 mg in combination with gemcitabine/cisplatin

Avelumab Gemcitabine Cisplatin

Trial Locations (46)

1122

"Orszagos Onkologiai Intezet C Belgyogyaszati - Onkologiai es Klinikai Farmakologiai Osztaly", Budapest

2010

St Vincent's Hospital Sydney, Darlinghurst

St Vincent's Public Hospital Sydney, Darlinghurst

2050

Chris O'Brien Lifehouse, Camperdown

3021

Western Health, Sunshine Hospital, St Albans

10461

Montefiore Medical Center - Einstein Center for Cancer Care, The Bronx

10467

Montefiore Medical Center - Moses Division, The Bronx

11794

Stony Brook Cancer Center, Stony Brook

Stony Brook University, Stony Brook

14059

Thomayerova nemocnice, Prague

20141

Istituto Europeo di Oncologia (IEO), Milan

20900

Centro di Ricerca di Fase 1, ASST Monza-Ospedale San Gerardo, Monza

Oncologia, ASST Monza-Ospedale San Gerardo, Monza

27710

Duke University Medical Center/Duke Cancer Center, Durham

Investigational Chemotherapy Service, Durham

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

46009

Fundacion Instituto Valenciano de Oncologia, Valencia

47014

IRCCS Istit.Scient.Romagnolo per lo Studio e la Cura dei Tumori, Meldola

60126

AOU Ospedali Riuniti di Ancona Umberto I - GM Lancisi - G Salesi, Torrette Di Ancona

80131

Istituto Nazionale Tumori di Napoli IRCCS Fondazione Pascale, Napoli

85719

University of Arizona Cancer Center - North Campus, Tucson

85724

Banner-University Medical Center Tucson, Tucson

K7L 2V7

Kingston Health Sciences Centre -, Kingston

779 00

Fakultni nemocnice Olomouc, Klinika nuklearni mediciny, Olomouc

Fakultni nemocnice Olomouc, Ustav klinicke a molekularni patologie, Olomouc

Fakultni nemocnice Olomouc, Olomouc

120 00

Vseobecna fakultni nemocnice v Praze, Prague

128 00

Vseobecna fakultni nemocnice v Praze, Prague

128 08

Vseobecna fakultni nemocnice v Praze, Prague

128 21

Vseobecna fakultni nemocnice v Praze, Prague

140 59

Thomayerova nemocnice, Prague

180 81

Centrum nuklearni mediciny s.r.o., Prague

190 61

Centrum nuklearni mediciny s.r.o., Prague

08035

Hospital Universitario Vall d'Hebron, Barcelona

08036

Hospital Clinic I Provincial, Barcelona

TR1 3LJ

Royal Cornwall Hospital, Truro

NW8 7JA

The Platinum Medical Centre, London

NW8 9LE

The Wellington Hospital - South, London

W1G 6AD

Sarah Cannon Research Institute UK, London

W1G 7LJ

The Harley Street Clinic, London

W1G 8HL

HCA Pharmacy Department, London

W1G 8PP

The Harley Street Clinic, London

W1U 5LZ

The Princess Grace Hospital, London

S10 2SJ

Weston Park Hospital, Sheffield

NE7 7DN

Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY